ANDA Litigation Settlements

Winter 2015

GENERICally Speaking
Case Name Drug Patent No(s). Publicly Available Terms

Helsinn Healthcare SA v. Dr. Reddy’s Labs. Ltd., 11-3962 (D.N.J.)

Aloxi®(palonosetron hydrochloride for injection)

7,947,724

7,947,725

 

Dr. Reddy’s will be allowed to market generic Aloxi on Sept. 30, 2018, or earlier under undisclosed circumstances.

Remaining terms are confidential.

Back to Top